Balleza Alejandri et al. Empagliflozin and Dapagliflozin Improve Endothelial Function in Mexican Patients with Type 2 Diabetes Mellitus: A Double-Blind Clinical Trial (vol 11,182,2024)

被引：0
|
作者：
Alejandri, Luis Ricardo Balleza [1 ]
Paez, Fernando Grover [1 ,2 ]
Campos, Erick Gonzalez [1 ]
Becerra, Carlos G. Ramos [1 ,2 ]
Munoz, Ernesto German Cardona [1 ,2 ]
Gonzalez, Sara Pascoe [1 ,2 ]
Zavala, Maria Guadalupe Ramos [1 ,2 ]
Roa, Africa Samantha Reynoso [1 ,2 ]
Rico, Daniel Osmar Suarez [1 ]
Ramirez, Alberto Beltran [1 ]
Galindo, Jesus Jonathan Garcia [1 ]
Mueller, David Cardona [1 ,2 ]
Ruiz, Claudia Yanette Galan [1 ,2 ]
机构：
[1] Univ Guadalajara, Univ Hlth Sci Ctr, Dept Physiol, Guadalajara 44340, Mexico
[2] Univ Guadalajara, Univ Hlth Sci Ctr, Expt & Clin Therapeut Inst, Dept Physiol,Arterial Stiffness Lab, Guadalajara 44340, Mexico
来源：
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE | 2024年 / 11卷 / 10期
关键词：
D O I：
10.3390/jcdd11100314
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Effects of L-carnitine supplementation on oxidative and metabolic status in patients with type 2 diabetes mellitus: A randomized, double-blind, clinical trial
    Talenezhad, Nasir
    Rahmanian, Masoud
    Mirzavandi, Farhang
    Hosseinzadeh, Mahdieh
    Fallahzadeh, Hossein
    Reza, Javad Zavar
    Mozaffari-Khosravi, Hassan
    EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE, 2020, 40
  • [22] Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial (vol 44, pg 1334, 2021)
    den Kamp, Yvo J. M. Op
    de Ligt, Marlies
    Dautzenberg, Bas
    Kornips, Esther
    Esterline, Russell
    Hesselink, Matthijs K. C.
    Hoeks, Joris
    Schrauwen-Hinderling, Vera B.
    Havekes, Bas
    Oscarsson, Jan
    Phielix, Esther
    Schrauwen, Patrick
    DIABETES CARE, 2022, 45 (05) : 1297 - 1297
  • [23] Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus:: A double-blind, randomized trial (vol 89, pg 6068, 2004)
    Schernthaner, G
    Matthews, DR
    Charbonnel, B
    Hanefeld, M
    Brunetti, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02): : 746 - 746
  • [24] Dapagliflozin decreases ambulatory central blood pressure and pulse wave velocity in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial
    Papadopoulou, Eirini
    Loutradis, Charalampos
    Tzatzagou, Glykeria
    Kotsa, Kalliopi
    Zografou, Ioanna
    Minopoulou, Ioanna
    Theodorakopoulou, Marietta P.
    Tsapas, Apostolos
    Karagiannis, Asterios
    Sarafidis, Pantelis
    JOURNAL OF HYPERTENSION, 2021, 39 (04) : 749 - 758
  • [25] Clinical Efficacy, Safety, and Tolerability of Single-Pill Combination of Dapagliflozin and Linagliptin in Uncontrolled Indian Type 2 Diabetes Mellitus Patients-A Randomized Double-Blind Study
    Ahmad, Jamal
    Ghosh, Sayan
    Kumthekar, Prashant P.
    Upadhyay, Mihir R.
    Sonawane, Kunal S.
    Khalse, Maneesha
    Patel, Kamlesh
    DIABETES, 2024, 73
  • [26] Effects of vitamin D supplementation on depressive symptoms in type 2 diabetes mellitus patients: Randomized placebo-controlled double-blind clinical trial
    Omidian, Mahsa
    Mahmoudi, Maryam
    Abshirini, Maryam
    Eshraghian, Mohammad Reza
    Javanbakht, Mohammad Hassan
    Zarei, Mahnaz
    Hasani, Hossein
    Djalali, Mahmoud
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2019, 13 (04) : 2375 - 2380
  • [27] Effects of saffron supplementation on glycemia and inflammation in patients with type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical trial study
    Mobasseri, Majid
    Ostadrahimi, Alireza
    Tajaddini, Aynaz
    Asghari, Samira
    Barati, Meisam
    Akbarzadeh, Moloud
    Nikpayam, Omid
    Houshyar, Jalil
    Roshanravan, Neda
    Alamdari, Naimeh Mesri
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (04) : 527 - 534
  • [28] Effects of pioglitazone and glimepiride on glycemic control and insulin sensitivity in Mexican patients with type 2 diabetes mellitus:: A multicenter, randomized, double-blind, parallel-group trial
    Tan, M
    Johns, D
    Gálvez, GG
    Antúnez, O
    Fabián, G
    Flores-Lozano, F
    Guajardo, SZ
    Garza, E
    Morales, H
    Konkoy, C
    Herz, M
    CLINICAL THERAPEUTICS, 2004, 26 (05) : 680 - 693
  • [29] Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial
    Kaku, K.
    Inoue, S.
    Matsuoka, O.
    Kiyosue, A.
    Azuma, H.
    Hayashi, N.
    Tokudome, T.
    Langkilde, A. M.
    Parikh, S.
    DIABETES OBESITY & METABOLISM, 2013, 15 (05): : 432 - 440
  • [30] Aggressive lipid lowering does not improve endothelial function in type 2 diabetes - The Diabetes Atorvastatin Lipid Intervention (DALI) study: a randomized, double-blind, placebo-controlled trial
    van Venrooij, FV
    van de Ree, MA
    Bots, ML
    Stolk, RP
    Huisman, MV
    Banga, JD
    DIABETES CARE, 2002, 25 (07) : 1211 - 1216
12345